MedPath

Cytokines in women with recurrent pregnancy loss

Not Applicable
Completed
Conditions
Health Condition 1: null- Women with recurrent pregnancy loss
Registration Number
CTRI/2010/091/000373
Lead Sponsor
Indian Council of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
360
Inclusion Criteria

1. Age group 18-35 years.

2. Women with history of at least three first trimester pregnancy loss and no history of successful pregnancy.

3. Women enrolled in first trimester preferably at 4-6 weeks of gestation. The pregnancy confirmation is done by estimating serum levels of beta hCG.

Exclusion Criteria

1. Women with 1 or 2 spontaneous abortions.
2. Women with known cause of RPL evaluated as per hospital protocol (anatomical, hormonal, chromosomal, autoimmune or infection).
3. Women who have taken Inj. hCG, proluton etc. during index pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a) To observe the cytokine levels of women with history of RPL and healthy pregnant control at the time of enrollment and the end of study and to compare the variation in their levels. <br/ ><br>b)To observe whether the administration of dydrogesterone causes any change in titers of Th1 (IFN-gamma, TNF-&#945;) and Th2 (IL-4, IL-10) cytokines.Timepoint: Three years
Secondary Outcome Measures
NameTimeMethod
Secondary outcome:- To find out how many pregnancies continued beyond 20 weeks of gestation and their pregnancy outcome and its correlation with cytokine levels and dydrogesterone administration.Timepoint: Three Years
© Copyright 2025. All Rights Reserved by MedPath